Skip to content

INSPIRE-LM: Intrathecal Trastuzumab + Pertuzumab in HER2+ Breast Cancer | ESMO 2026

Dr. Elisabetta BonzanoIRCCS Policlinico San Matteo

Type: Expert pick
Congress: ESMO 2026
Published: November 8, 2026
Topic: Breast

More on breast cancer

Everything on breast cancer

PI3K Pathway in HR+/HER2– Breast Cancer: Testing, Treatment & the Next Wave | Drs. Pistilli & Saura
Expert pick. November 5, 2026.
evERA : Giredestrant + Everolimus: evERA Biomarker Analyses | Sara Tolaney | ESMO 2026
Dr. Sara Tolaney. Trial update. ESMO 2026.
NATALEE 6-Year Update: Overall Survival Benefit With Ribociclib | ESMO 2026
Dr. Gil Morgan. Expert pick. ESMO 2026. Day 2.
TOP-1 Trial: Can We Omit Both Radiotherapy and Endocrine Therapy?
Dr. Elisabetta Bonzano. Expert pick. ESMO 2026. Day 2.
Safety of combining radiation therapy and antibody-drug conjugates in patients with breast cancer: a systematic review and meta-analysis
Publication pick. Radiotherapy & Oncology. October 15, 2026.
Advances in Systemic Treatment of Breast Cancer (Review)
Publication pick. NEJM. October 12, 2026.

The OncoAlert Newsletter goes to 10,000+ oncologists and cancer stakeholders: every week, and every day during the major congresses. Free, independent, GDPR-compliant and easy to leave.

Email address

Your role

Your country

How we use your details